Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccines

Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccines

The lack of validated immunological correlates of protection makes tuberculosis vaccine development difficult and expensive. Using intradermal bacille Calmette-Guréin (BCG) as a surrogate for aerosol Mycobacterium tuberculosis (M.tb) in a controlled human infection model could facilitate vaccine dev...

Detaylı Bibliyografya
Asıl Yazarlar:	Harris, S, White, A, Stockdale, L, Tanner, R, Sibley, L, Sarfas, C, Meyer, J, Peter, J, O'Shea, M, Manjaly Thomas, Z, Hamidi, A, Satti, I, Dennis, M, McShane, H, Sharpe, S
Materyal Türü:	Journal article
Baskı/Yayın Bilgisi:	Elsevier 2017

Benzer Materyaller

A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates
Yazar:: Tanner, R, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Optimisation of a human BCG challenge model
Yazar:: Wilkie, M, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

MTBVAC induces superior antibody titers and IgG avidity compared to BCG vaccination in non-human primates
Yazar:: Peralta-Álvarez, MP, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate TB vaccine, MVA85A, alone and in combination
Yazar:: Harris, S, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate tuberculosis vaccine, MVA85A, alone and in combination.
Yazar:: Harris, SA, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

MTBVAC induces superior antibody titers and IgG avidity compared to BCG vaccination in non-human primates
Yazar:: Marco Polo Peralta-Álvarez, ve diğerleri
Baskı/Yayın Bilgisi: (2024-11-01)

The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells
Yazar:: Tanner, R, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates
Yazar:: Rachel Tanner, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Low-dose M.tb infection but not BCG or MTBVAC vaccination enhances heterologous antibody titres in non-human primates
Yazar:: Alvarez, MPP, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

A first-in-human phase 1 trial to evaluate the safety and immunogenicity of the candidate tuberculosis vaccine MVA85A-IMX313, administered to BCG-vaccinated adults.
Yazar:: Minhinnick, A, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Low-dose M.tb infection but not BCG or MTBVAC vaccination enhances heterologous antibody titres in non-human primates
Yazar:: Marco Polo Peralta Alvarez, ve diğerleri
Baskı/Yayın Bilgisi: (2024-05-01)

The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells [version 1; peer review: 2 approved]
Yazar:: Rachel Tanner, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells [version 2; peer review: 2 approved]
Yazar:: Rachel Tanner, ve diğerleri
Baskı/Yayın Bilgisi: (2021-09-01)

Gene expression and cytokine profile correlate with mycobacterial growth in a human BCG challenge model
Yazar:: Matsumiya, M, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Immune cell population dynamics following neonatal BCG vaccination and aerosol BCG revaccination in rhesus macaques
Yazar:: Laura Sibley, ve diğerleri
Baskı/Yayın Bilgisi: (2024-07-01)

A Phase I, Open-Label Trial, Evaluating the Safety and Immunogenicity of Candidate Tuberculosis Vaccines AERAS-402 and MVA85A, Administered by Prime-Boost Regime in BCG-Vaccinated Healthy Adults
Yazar:: Sheehan, S, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial.
Yazar:: Satti, I, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Spore-FP1 tuberculosis mucosal vaccine candidate is highly protective in guinea pigs but fails to improve on BCG-conferred protection in non-human primates
Yazar:: Andrew D. White, ve diğerleri
Baskı/Yayın Bilgisi: (2023-10-01)

Development of a primate model for tuberculosis vaccine research: IFN-gamma responses induced by BCG vaccination and M-tuberculosis infection in macaques
Yazar:: Dowall, S, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Induction of functional specific antibodies, IgG-secreting plasmablasts and memory B cells following BCG vaccination
Yazar:: Bitencourt, J, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

IV BCG Vaccination and Aerosol BCG Revaccination Induce Mycobacteria-Responsive γδ T Cells Associated with Protective Efficacy against <i>M. tb</i> Challenge
Yazar:: Alexandra L. Morrison, ve diğerleri
Baskı/Yayın Bilgisi: (2023-10-01)

T-cell activation is an immune correlate of risk in BCG vaccinated infants
Yazar:: Fletcher, H, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Predicting IFN-γ responses after BCG vaccination in humans from macaques: A proof-of-concept study of Immunostimulation/Immunodynamic modelling methods
Yazar:: Rhodes, S, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Comparison of the safety and immunogenicity of a candidate TB vaccine, MVA85A, given by the intramuscular or intradermal route in BCG-vaccinated adults
Yazar:: Harris, S, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Corrigendum: T-cell activation is an immune correlate of risk in BCG vaccinated infants.
Yazar:: Fletcher, H, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG.
Yazar:: Fletcher, H, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle
Yazar:: Villarreal-Ramos, B, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Process of Assay Selection and Optimization for the Study of Case and Control Samples from a Phase IIb Efficacy Trial of a Candidate Tuberculosis Vaccine, MVA85A
Yazar:: Harris, SA, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: A phase 1, double-blind, randomised controlled trial
Yazar:: Satti, I, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Characterization of the Infant Immune System and the Influence and Immunogenicity of BCG Vaccination in Infant and Adult Rhesus Macaques
Yazar:: Charlotte Sarfas, ve diğerleri
Baskı/Yayın Bilgisi: (2021-10-01)

The humoral immune response to BCG vaccination
Yazar:: Tanner, R, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection
Yazar:: O'Shea, M, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Revaccination with BCG: does it work?
Yazar:: McShane, H
Baskı/Yayın Bilgisi: (2024)

Understanding BCG is the key to improving it.
Yazar:: McShane, H
Baskı/Yayın Bilgisi: (2013)

Induction of Functional Specific Antibodies, IgG-Secreting Plasmablasts and Memory B Cells Following BCG Vaccination
Yazar:: Julia Bitencourt, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

T-cell activation is an immune correlate of risk in BCG vaccinated infants
Yazar:: Helen A. Fletcher, ve diğerleri
Baskı/Yayın Bilgisi: (2016-04-01)

Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants
Yazar:: Satti, I, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Optimization of a human bacille Calmette-Guerin challenge model: a tool to evaluate antimycobacterial immunity
Yazar:: Minhinnick, A, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy.
Yazar:: Minassian, A, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

TB and SIV Coinfection; a Model for Evaluating Vaccine Strategies against TB Reactivation in Asian Origin Cynomolgus Macaques: A Pilot Study Using BCG Vaccination
Yazar:: Andrew D. White, ve diğerleri
Baskı/Yayın Bilgisi: (2021-08-01)